MassBio represents 1,200+ life sciences companies and organizations involved with the industry. We are available to comment and provide background on public policy, economic development, education, workforce development and other key life sciences issues.
Gov. Baker filed interim budget; KSA released a report on improving transportation; President Trump expected to issue executive order; and the Senate HELP committee will vote on a healthcare bill Read More
Gov. Charlie Baker delayed paid leave taxes; the MA Prescription Drug Affordability Coalition held an advocacy day; the federal House Ways and Means held a hearing on universal health coverage. Read More
MA Senate budget debate was completed; MA HPC held a public listening session on co-pay assistance; the House Energy and Commerce Health Subcommittee held a hearing on drug pricing transparency. Read More
MassBio launched an advocacy campaign, CMS issued guidance on spread pricing and won't proceed with its proposal on the six protected classes of drugs. MA Senate Budget debate begins this week. Read More
The MA Senate released its version of the FY2020 budget; CMS released a final rule requiring list prices of drugs to be included in TV ads; and MassBio launches an legislative advocacy campaign. Read More
Last week, the MA House of Reps took up their FY2020 budget. This week, a bill to restrict patent trolls is considered. And the Health Policy Commission is looking to study co-pay assistance. Read More